Dietary Intervention and Vascular Function
DIVAS
The Effects of the Substitution of Dietary SFA With n-6 PUFA or MUFA on Vascular Function
1 other identifier
interventional
202
1 country
2
Brief Summary
It is well established that diet plays an important role in both the development and progression of heart disease. Different types of dietary fat have varying effects on heart disease risk factors. The elasticity of an individual's blood vessels is strongly associated with heart disease risk and recent evidence suggests that dietary manipulation may influence elasticity of the blood vessels with dietary fat (including saturated, monounsaturated and polyunsaturated fatty acids) as a potentially important modulator. Substantial evidence exists on the effects of monounsaturated fats (type of fatty acids mainly found in olive and rapeseed oil), n-6 polyunsaturated fats (type of polyunsaturated fatty acids found in vegetable oils) and saturated fat (found mainly in animal derived products) on lipid levels. However, the influence of these dietary fats on the elasticity of blood vessels remains unclear.The main purpose of the DIVAS study is to determine the effects of the substitution of saturated fats with either n-6 polyunsaturated or monounsaturated fats on blood vessel elasticity and to determine the effects of these different dietary fats on other risk factors for heart disease including lipoproteins and inflammatory biomarkers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2010
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 16, 2011
CompletedFirst Posted
Study publicly available on registry
November 23, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedResults Posted
Study results publicly available
July 15, 2014
CompletedJuly 15, 2014
June 1, 2014
2.4 years
November 16, 2011
May 13, 2014
June 12, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent Change in Flow Mediated Dilatation (FMD)
Baseline, 4 months
Secondary Outcomes (4)
Cardiovascular Risk Factors (Lipids, Inflammatory Markers, Indices of Insulin Resistance, Cell Microparticles, Endothelial Progenitor Cells)
4 months
24-hour Ambulatory Blood Pressure
4 months
Vascular Stiffness by Pulse Wave Velocity (PWV), Pulse Wave Analysis (PWA) and Digital Volume Pulse (DVP)
4 months
Microvascular Reactivity (Laser Doppler Imaging With Iontophoresis)
4 months
Study Arms (3)
high saturated fat diet
ACTIVE COMPARATORhigh monounsaturated fat diet
EXPERIMENTALhigh n-6 polyunsaturated fat diet
EXPERIMENTALInterventions
Volunteers are following a high saturated fat diet for a 4-month period
Volunteers are following a high monounsaturated fat diet for a 4-month period
Volunteers are following a high n-6 polyunsaturated fat diet for a 4-month period
Eligibility Criteria
You may qualify if:
- Adults should have a relative risk (RR) of \> 1.5 of developing cardiovascular disease (CVD) based on presenting with at least one recognised risk factor for CVD:
- total cholesterol (TC) \> 6.0 mmol/l
- HDL cholesterol (HDLC) ≤ 1.0 mmol/l male, ≤ 1.3 mmol/l female
- Glucose ≥ 6 mmol/l
- Stage 1 hypertension or above i.e. a systolic BP ≥ 140 mmHg, diastolic BP ≥ 90 mmHg
- BMI 28-35 kg/m2
- waist \>102 cm male or \> 84 cm female
- Adults with a first degree relative with either a history of premature CVD - age of onset younger than 55 y in fathers, sons or brothers or younger than 65 y in mothers, daughters or sisters, or type 2 diabetes.
You may not qualify if:
- having suffered a myocardial infarction/stroke in the past 12 months
- diabetic (diagnosed or fasting glucose \> 7 mmol/l) or suffer from other endocrine disorders
- suffering from renal or bowel disease or have a history of choleostatic liver or pancreatitis
- on drug treatment for hyperlipidaemia, hypertension, inflammation or hypercoagulation
- no history of alcohol abuse
- planning or on a weight reducing regime
- taking any fish oil, fatty acid or vitamin and mineral supplements
- pregnant, lactating or planning a pregnancy
- smokers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Department of Food and Nutritional Sciences, University of Reading
Reading, Berkshire, RG6 6AP, United Kingdom
University of Reading
Reading, Berkshire, RG6 6AP, United Kingdom
Related Publications (5)
Sellem L, Eichelmann F, Jackson KG, Wittenbecher C, Schulze MB, Lovegrove JA. Replacement of dietary saturated with unsaturated fatty acids is associated with beneficial effects on lipidome metabolites: a secondary analysis of a randomized trial. Am J Clin Nutr. 2023 Jun;117(6):1248-1261. doi: 10.1016/j.ajcnut.2023.03.024. Epub 2023 Apr 11.
PMID: 37062359DERIVEDWeech M, Altowaijri H, Mayneris-Perxachs J, Vafeiadou K, Madden J, Todd S, Jackson KG, Lovegrove JA, Yaqoob P. Replacement of dietary saturated fat with unsaturated fats increases numbers of circulating endothelial progenitor cells and decreases numbers of microparticles: findings from the randomized, controlled Dietary Intervention and VAScular function (DIVAS) study. Am J Clin Nutr. 2018 Jun 1;107(6):876-882. doi: 10.1093/ajcn/nqy018.
PMID: 29741564DERIVEDShatwan IM, Weech M, Jackson KG, Lovegrove JA, Vimaleswaran KS. Apolipoprotein E gene polymorphism modifies fasting total cholesterol concentrations in response to replacement of dietary saturated with monounsaturated fatty acids in adults at moderate cardiovascular disease risk. Lipids Health Dis. 2017 Nov 23;16(1):222. doi: 10.1186/s12944-017-0606-3.
PMID: 29169396DERIVEDVafeiadou K, Weech M, Altowaijri H, Todd S, Yaqoob P, Jackson KG, Lovegrove JA. Replacement of saturated with unsaturated fats had no impact on vascular function but beneficial effects on lipid biomarkers, E-selectin, and blood pressure: results from the randomized, controlled Dietary Intervention and VAScular function (DIVAS) study. Am J Clin Nutr. 2015 Jul;102(1):40-8. doi: 10.3945/ajcn.114.097089. Epub 2015 May 27.
PMID: 26016869DERIVEDWeech M, Vafeiadou K, Hasaj M, Todd S, Yaqoob P, Jackson KG, Lovegrove JA. Development of a food-exchange model to replace saturated fat with MUFAs and n-6 PUFAs in adults at moderate cardiovascular risk. J Nutr. 2014 Jun;144(6):846-55. doi: 10.3945/jn.114.190645. Epub 2014 Apr 9.
PMID: 24717370DERIVED
MeSH Terms
Conditions
Results Point of Contact
- Title
- Professor Julie Lovegrove
- Organization
- University of Reading
Study Officials
- PRINCIPAL INVESTIGATOR
Julie A Lovegrove, BSc PhD RNutr
University of Reading
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 16, 2011
First Posted
November 23, 2011
Study Start
May 1, 2010
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
July 15, 2014
Results First Posted
July 15, 2014
Record last verified: 2014-06